Arm is a British semi-conductor and software design company. Arm committed £1 million to Gavi in 2021, which was matched by the Gavi Matching Fund.
This commenced a new strategic partnership between Gavi, Arm and UK-based non-profit Simprints, to help solve the global identification gap. The partnership aims to develop a unique, contactless, digital identification solution that is accurate, scalable and cost-effective.
Guided by Gavi’s expertise in immunisation, the project deploys Simprints’ biometrics solution with support from Arm’s technology, global network and funding. In 2023, Arm committed a further £1 million to Gavi, which was also matched by the Gavi Matching Fund.
Through this agreement, over two years Arm will invest £1 million in INFUSE. Of this, Arm has earmarked half the amount to continue support of an expanded project of contactless biometrics for immunisation to be implemented by Simprints. The other half of the funding will be allocated to other INFUSE Pacesetters sourced and recommended by Gavi, and approved by Arm.
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: